Traumatic Brain Injury Disrupts the Brain's Endocannabinoid System, Worsening Damage

After traumatic brain injury in mice, endocannabinoid levels dropped due to increased metabolizing enzyme activity, which was associated with brain barrier damage, reduced blood flow, and anxiety-like behavior.

Ahluwalia, Meenakshi et al.·Experimental neurology·2023·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-04352Animal StudyPreliminary Evidence2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

TBI increased expression of enzymes that break down endocannabinoids (MAGL, FAAH, Cox-2), leading to reduced 2-AG and AEA levels in plasma. This was accompanied by compromised brain-CSF barrier integrity, increased neuroinflammatory markers (IBA1, GFAP), reduced cerebral blood flow, altered aquaporin-4 expression, reduced ventricular volume, motor deficits, and anxiety behaviors. Preliminary human CSF data also showed endocannabinoid changes after TBI.

Key Numbers

Reduced 2-AG and AEA plasma levels; increased MAGL, FAAH, and Cox-2; increased CB2 and TRPV1 expression; increased AQP4, IBA1, GFAP; reduced cerebral blood flow; reduced ventricular volume; motor deficits and anxiety behaviors; preliminary human data corroborative

How They Did This

Controlled cortical impact mouse model of TBI. Measured endocannabinoid levels and metabolizing enzymes in brain tissue. Assessed brain-CSF barrier integrity, cerebral blood flow, neuroinflammation markers, ventricular volume, and behavior. Preliminary analysis of human CSF and plasma endocannabinoid levels included.

Why This Research Matters

TBI affects millions annually with limited treatment options. If endocannabinoid loss after brain injury worsens outcomes, then blocking the enzymes that break down endocannabinoids could represent a new therapeutic approach to reduce secondary brain damage.

The Bigger Picture

The endocannabinoid system appears to be a natural neuroprotective mechanism that becomes depleted after brain injury. Understanding this depletion could lead to drugs that boost endocannabinoid levels (such as FAAH or MAGL inhibitors) as treatments for the chronic consequences of TBI.

What This Study Doesn't Tell Us

Mouse CCI model represents one specific type of TBI and may not reflect the full spectrum of human head injuries. Human data is preliminary and not fully detailed. Cannot determine whether endocannabinoid changes cause secondary damage or are simply a marker of injury severity.

Questions This Raises

  • ?Would FAAH or MAGL inhibitors given after TBI improve outcomes?
  • ?At what time point post-injury would endocannabinoid-boosting therapy be most effective?
  • ?Do different types of TBI produce different endocannabinoid changes?

Trust & Context

Key Stat:
Endocannabinoid depletion after TBI
Evidence Grade:
Comprehensive preclinical study with multiple outcome measures and preliminary human data, but animal model limits direct clinical application
Study Age:
2023 study
Original Title:
Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.
Published In:
Experimental neurology, 361, 114320 (2023)
Database ID:
RTHC-04352

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Could cannabis help after a brain injury?

This study suggests the body's natural cannabinoid system becomes depleted after brain injury, and this depletion may worsen outcomes. However, using cannabis directly after TBI has not been tested and could have unpredictable effects.

What happens to endocannabinoids after brain injury?

The brain ramps up production of enzymes that break down endocannabinoids, causing their levels to drop. This loss of natural neuroprotective compounds was associated with brain barrier damage, inflammation, and behavioral problems in mice.

Read More on RethinkTHC

Cite This Study

RTHC-04352·https://rethinkthc.com/research/RTHC-04352

APA

Ahluwalia, Meenakshi; Mcmichael, Hannah; Kumar, Manish; Espinosa, Mario P; Bosomtwi, Asamoah; Lu, Yujiao; Khodadadi, Hesam; Jarrahi, Abbas; Khan, Mohammad Badruzzaman; Hess, David C; Rahimi, Scott Y; Vender, John R; Vale, Fernando L; Braun, Molly; Baban, Babak; Dhandapani, Krishnan M; Vaibhav, Kumar. (2023). Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.. Experimental neurology, 361, 114320. https://doi.org/10.1016/j.expneurol.2023.114320

MLA

Ahluwalia, Meenakshi, et al. "Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.." Experimental neurology, 2023. https://doi.org/10.1016/j.expneurol.2023.114320

RethinkTHC

RethinkTHC Research Database. "Altered endocannabinoid metabolism compromises the brain-CSF..." RTHC-04352. Retrieved from https://rethinkthc.com/research/ahluwalia-2023-altered-endocannabinoid-metabolism-compromises

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.